Barclays »

Terns Pharmaceuticals shares owned by Barclays

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Barclays

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.1M 129k 8.35
2024-06-30 $1.3M 195k 6.81
2024-03-31 $1.6M 248k 6.56
2023-12-31 $548k 85k 6.48
2023-09-30 $274k 54k 5.04
2023-06-30 $2.3M 263k 8.75
2023-03-31 $6.3M 535k 11.84
2022-12-31 $5.3M 517k 10.18
2022-09-30 $3.9M 659k 5.89
2022-06-30 $33k 13k 2.51
2022-03-31 $46k 15k 3.00